Syringes cannot be evaluated using a one-size-fits-all checklist. The syringe design, drug product, and intended use all influence which tests are most important and how acceptance criteria are established.
Consider an arthritis biologic and an emergency drug such as epinephrine. Both may use similar container closure systems and baseline test methods. However, the way those methods are applied, and what qualifies as an acceptable result, can differ significantly.
The Same Test Methods, Different Requirements
Manufacturers evaluating prefilled syringes for autoinjector use commonly reference ISO 11040. Part 8 addresses the finished, assembled container system, while Parts 4 and 6 address glass and plastic syringe barrels, respectively. Container closure integrity and break loose and glide force testing are common starting points across drug products.
From there, testing becomes more specific to the application. Manufacturers establish additional design inputs based on the therapy, device, user population, and delivery conditions. As a result, two products may use the same test method but require very different acceptance criteria.
Delivery Speed: Ten Seconds vs. One Second
Arthritis biologics and emergency drugs often sit at opposite ends of the delivery-speed spectrum. An arthritis therapy may be designed for a controlled injection lasting approximately ten seconds. An emergency drug may need to deliver the full dose within one or two seconds.
Delivery time affects more than patient comfort. It also influences the autoinjector’s power pack—the mechanism that advances the plunger—and the device’s overall design. A patient with limited grip strength or dexterity may need to hold an arthritis autoinjector steady and perpendicular to the injection site for the entire dose. Removing the device too early can result in a wet injection, meaning some of the drug remains on the skin instead of being delivered. For an emergency autoinjector, rapid dose delivery becomes the primary design consideration.
Break Loose and Glide Force
Break loose force is the initial force required to move the plunger. Glide force is the force needed to continue moving it through the remainder of the dose. In some European applications, these measurements may be described as break loose and extrusion force. Although both products may be evaluated using methods referenced in ISO 11040-8, the test speed and acceptance criteria should reflect the intended delivery profile.
Break loose force deserves careful consideration. Many arthritis therapies are self-administered or given by a caregiver, so the force required to initiate delivery must be appropriate for a broad user population. Regardless of the application, break loose and glide forces may change over the product’s shelf life. Testing should therefore account for the anticipated shelf life rather than focusing only on time-zero performance.
Syringe Selection
Syringe selection should support the product’s delivery requirements. Glass syringes are widely used and typically include a lubrication layer to support plunger movement. Cyclic olefin polymer (COP) syringes generally come at a higher cost but can provide dimensional stability, chemical resistance, and an alternative to siliconized glass. These characteristics may carry greater weight when rapid and consistent delivery is critical.
Needle gauge and inner diameter also influence the injection experience and the consistency of dose delivery. Because the syringe barrel, plunger, lubrication system, and needle all interact, a small change to one component can affect the device’s overall force profile. This is why the pre-filled syringe should be evaluated as a complete system rather than as a collection of isolated components.
Key Takeaway
Pre-filled syringe and auto-injector testing should be based on the drug’s therapeutic use, delivery time, and intended user. Although arthritis biologics and emergency drugs may undergo many of the same evaluations, their acceptance criteria can differ significantly. Factors such as break loose and glide force, syringe material, lubrication, needle dimensions, component tolerances, and shelf-life performance all influence how the device functions. Rather than relying on a generic checklist, manufacturers should develop a testing strategy around the product’s specific use case.